Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells

Journal of Virology

Volumn 83, Issue 19, 2009, Pages 9854-9862

  Uchida, Naoya ^a,b,c   Washington, Kareem N ^a   Hayakawa, Jun ^a   Hsieh, Matthew M ^a   Bonifacino, Aylin C ^a   Krouse, Allen E ^a   Metzger, Mark E ^a   Donahue, Robert E ^a   Tisdale, John F ^a,d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c Molecular Genetics   (Japan)

^d Molecular and Clinical Hematology Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; LENTIVIRUS VECTOR; VIF PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD; BLOOD CELL; CELL LINEAGE; CHIMERA; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CAPSID;

ANIMALS; ANTIGENS, CD34; CAPSID; CELL LINE; ERYTHROCYTES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HIV-1; HUMANS; LENTIVIRUS; MACACA MULATTA; MODELS, GENETIC; MUTATION; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSDUCTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 70349290584     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00357-09     Document Type: Article

References (41)

1. Aiuti, A., S. Slavin, M. Aker, F. Ficara, S. Deola, A. Mortellaro, S. Morecki, G. Andolfi, A. Tabucchi, F. Carlucci, E. Marinello, F. Cattaneo, S. Vai, P. Servida, R. Miniero, M. G. Roncarolo, and C. Bordignon. 2002. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296:2410-2413. (Pubitemid 34734219)
2. An, D. S., S. K. Kung, A. Bonifacino, R. P. Wersto, M. E. Metzger, B. A. Agricola, S. H. Mao, I. S. Chen, and R. E. Donahue. 2001. Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques. J. Virol. 75:3547-3555.
3. An, D. S., R. P. Wersto, B. A. Agricola, M. E. Metzger, S. Lu, R. G. Amado, I. S. Chen, and R. E. Donahue. 2000. Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells. J. Virol. 74:1286-1295.
4. Bhanu, N. V., T. A. Trice, Y. T. Lee, and J. L. Miller. 2004. A signaling mechanism for growth-related expression of fetal hemoglobin. Blood 103:1929-1933. (Pubitemid 38268993)
5. Bogerd, H. P., B. P. Doehle, H. L. Wiegand, and B. R. Cullen. 2004. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101:3770-3774.
6. Cavazzana-Calvo, M., S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, P. Bousso, F. L. Deist, and A. Fischer. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669-672. (Pubitemid 30241569)
7. Chiu, Y. L., V. B. Soros, J. F. Kreisberg, K. Stopak, W. Yonemoto, and W. C. Greene. 2005. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435:108-114.
8. Donahue, R. E., M. R. Kirby, M. E. Metzger, B. A. Agricola, S. E. Sellers, and H. M. Cullis. 1996. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644-1653. (Pubitemid 26056933)
9. Donahue, R. E., K. Kuramoto, and C. E. Dunbar. November 2005. Large animal models for stem and progenitor cell analysis, chapter 22, unit 22A 1. Current protocols in immunology. Wiley Interscience, Hoboken, NJ. http://mrw.interscience.wiley.com/emrw/9780471142737/cp/cpim/article/im22a01/ current/abstract.
10. Goila-Gaur, R., and K. Strebel. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5:51.
11. Hacein-Bey-Abina, S., A. Garrigue, G. P. Wang, J. Soulier, A. Lim, E. Morillon, E. Clappier, L. Caccavelli, E. Delabesse, K. Beldjord, V. Asnafi, E. MacIntyre, L. Dal Cortivo, I. Radford, N. Brousse, F. Sigaux, D. Moshous, J. Hauer, A. Borkhardt, B. H. Belohradsky, U. Wintergerst, M. C. Velez, L. Leiva, R. Sorensen, N. Wulffraat, S. Blanche, F. D. Bushman, A. Fischer, and M. Cavazzana-Calvo. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Investig. 118:3132-3142.
12. Hacein-Bey-Abina, S., C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-256.
13. Hanawa, H., P. Hematti, K. Keyvanfar, M. E. Metzger, A. Krouse, R. E. Donahue, S. Kepes, J. Gray, C. E. Dunbar, D. A. Persons, and A. W. Nienhuis. 2004. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103:4062-4069. (Pubitemid 38685345)
14. Hanawa, H., P. F. Kelly, A. C. Nathwani, D. A. Persons, J. A. Vandergriff, P. Hargrove, E. F. Vanin, and A. W. Nienhuis. 2002. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol. Ther. 5:242-251.
15. Hanawa, H., D. A. Persons, and A. W. Nienhuis. 2005. Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors. J. Virol. 79:8410-8421. (Pubitemid 40853543)
16. Hatziioannou, T., M. Princiotta, M. Piatak, Jr., F. Yuan, F. Zhang, J. D. Lifson, and P. D. Bieniasz. 2006. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314:95. (Pubitemid 44547747)
17. Hayakawa, J., T. Ueda, L. Lisowski, M. M. Hsieh, K. Washington, O. Phang, M. Metzger, A. Krouse, R. E. Donahue, M. Sadelain, and J. F. Tisdale. 2009. Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the non-human primate. Hum. Gene Ther. 20:563-572.
18. Hematti, P., B. K. Hong, C. Ferguson, R. Adler, H. Hanawa, S. Sellers, I. E. Holt, C. E. Eckfeldt, Y. Sharma, M. Schmidt, C. von Kalle, D. A. Persons, E. M. Billings, C. M. Verfaillie, A. W. Nienhuis, T. G. Wolfsberg, C. E. Dunbar, and B. Calmels. 2004. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2:e423. (Pubitemid 40280522)
19. Hematti, P., S. Tuchman, A. Larochelle, M. E. Metzger, R. E. Donahue, and J. F. Tisdale. 2004. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates. Stem Cells 22:1062-1069. (Pubitemid 39507092)
20. Kao, S., H. Akari, M. A. Khan, M. Dettenhofer, X. F. Yu, and K. Strebel. 2003. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. J. Virol. 77:1131-1140. (Pubitemid 36055535)
21. Kootstra, N. A., C. Munk, N. Tonnu, N. R. Landau, and I. M. Verma. 2003. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. USA 100:1298-1303.
22. Mariani, R., D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N. R. Landau. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31. (Pubitemid 36859838)
23. May, C., S. Rivella, J. Callegari, G. Heller, K. M. Gaensler, L. Luzzatto, and M. Sadelain. 2000. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 406:82-86.
24. Mitchell, R. S., B. F. Beitzel, A. R. Schroder, P. Shinn, H. Chen, C. C. Berry, J. R. Ecker, and F. D. Bushman. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:E234.
25. Newman, E. N., R. K. Holmes, H. M. Craig, K. C. Klein, J. R. Lingappa, M. H. Malim, and A. M. Sheehy. 2005. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15:166-170.
26. Newman, R. M., L. Hall, A. Kirmaier, L. A. Pozzi, E. Pery, M. Farzan, S. P. O'Neil, and W. Johnson. 2008. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog 4:e1000003.
27. Nienhuis, A. W. 2008. Development of gene therapy for blood disorders. Blood 111:4431-4444.
28. Ott, M. G., M. Schmidt, K. Schwarzwaelder, S. Stein, U. Siler, U. Koehl, H. Glimm, K. Kuhlcke, A. Schilz, H. Kunkel, S. Naundorf, A. Brinkmann, A. Deichmann, M. Fischer, C. Ball, I. Pilz, C. Dunbar, Y. Du, N. A. Jenkins, N. G. Copeland, U. Luthi, M. Hassan, A. J. Thrasher, D. Hoelzer, C. von Kalle, R. Seger, and M. Grez. 2006. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12:401-409.
29. Rits, M. A., K. A. van Dort, C. Munk, A. B. Meijer, and N. A. Kootstra. 2007. Efficient transduction of simian cells by HIV-1-based lentiviral vectors that contain mutations in the capsid protein. Mol. Ther. 15:930-937.
30. Ryu, B. Y., M. V. Evans-Galea, J. T. Gray, D. M. Bodine, D. A. Persons, and A. W. Nienhuis. 2008. An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation. Blood 111:1866-1875.
31. Sakuma, R., J. A. Noser, S. Ohmine, and Y. Ikeda. 2007. Inhibition of HIV-1 replication by simian restriction factors, TRIM5α and APOBEC3G. Gene Ther. 14:185-189. (Pubitemid 46043824)
32. Schmidt, M., P. Zickler, G. Hoffman, S. Haas, M. Wissler, A. Muessig, J. F. Tisdale, R. G. Andrews, T. Wu, H.-P. Kiem, C. E. Dunbar, and C. von Kalle. 2002. Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100:2737-2743.
33. Schwarzwaelder, K., S. J. Howe, M. Schmidt, M. H. Brugman, A. Deichmann, H. Glimm, S. Schmidt, C. Prinz, M. Wissler, D. J. King, F. Zhang, K. L. Parsley, K. C. Gilmour, J. Sinclair, J. Bayford, R. Peraj, K. Pike-Overzet, F. J. Staal, D. de Ridder, C. Kinnon, U. Abel, G. Wagemaker, H. B. Gaspar, A. J. Thrasher, and C. von Kalle. 2007. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J. Clin. Investig. 117:2241-2249.
34. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
35. Simon, J. H., D. L. Miller, R. A. Fouchier, M. A. Soares, K. W. Peden, and M. H. Malim. 1998. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17:1259-1267.
36. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
37. Stremlau, M., M. Perron, M. Lee, Y. Li, B. Song, H. Javanbakht, F. Diaz-Griffero, D. J. Anderson, W. I. Sundquist, and J. Sodroski. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5α restriction factor. Proc. Natl. Acad. Sci. USA 103:5514-5519.
38. Tisdale, J. F., Y. Hanazono, S. E. Sellers, B. A. Agricola, M. E. Metzger, R. E. Donahue, and C. E. Dunbar. 1998. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92:1131-1141.
39. Trobridge, G. D., B. C. Beard, C. Gooch, M. Wohlfahrt, P. Olsen, J. Fletcher, P. Malik, and H. P. Kiem. 2008. Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors. Blood 111:5537-5543.
40. Wu, X., Y. Li, B. Crise, and S. M. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751. (Pubitemid 36712571)
41. Zychlinski, D., A. Schambach, U. Modlich, T. Maetzig, J. Meyer, E. Grassman, A. Mishra, and C. Baum. 2008. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol. Ther. 16:718-725.